Response of Renal Cell Carcinoma Pancreatic Metastasis to Sunitinib Treatment: Retrospective Analysis EDITORIAL COMMENT

被引：0
|
作者：
Matin, Surena F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
来源：
JOURNAL OF UROLOGY | 2009年 / 181卷 / 06期
关键词：
D O I：
10.1016/j.juro.2009.02.163
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2475 / 2475
页数：1
相关论文
共 50 条
  • [31] Re: Efficacy and Toxicity of Sunitinib in Patients With Metastatic Renal Cell Carcinoma With Severe Renal Impairment or in Haemodialysis Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2012, 187 (04): : 1223 - 1224
  • [32] Editorial Comment from Dr Yokomizo to Efficacy of traditional and alternative sunitinib treatment schedules in Japanese patients with metastatic renal cell carcinoma
    Yokomizo, Akira
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 (10) : 1069 - 1069
  • [33] Multicenter retrospective study on new biomarkers predictive of response to sunitinib in metastatic renal cell carcinoma
    Pinotti, G.
    Bolzacchini, E.
    Tuzi, A.
    Tartaro, T.
    Proserpio, I.
    Mare, M.
    Vallini, I.
    Verusio, C.
    Rossini, C.
    Ballerio, A.
    Bregni, M.
    Barzaghi, S.
    Artale, S.
    Ricci, I.
    Danova, M.
    Galli, L.
    Cecila, B.
    Mumoli, N.
    Dentali, F.
    ANNALS OF ONCOLOGY, 2016, 27
  • [34] Experience with sunitinib in the treatment of metastatic renal cell carcinoma
    Schmidinger, Manuela
    Larkin, James
    Ravaud, Alain
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (05) : 253 - 265
  • [35] Thyrotoxicosis during sunitinib treatment for renal cell carcinoma
    Grossmann, Mathis
    Premaratne, Erosha
    Desai, Jayesh
    Davis, Ian D.
    CLINICAL ENDOCRINOLOGY, 2008, 69 (04) : 669 - 672
  • [36] Sunitinib (SUTENT®) for the treatment of metastatic renal cell carcinoma
    Hutson, Thomas E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (11) : 1723 - 1731
  • [37] Treatment of Hemodialyzed Patients with Sunitinib in Renal Cell Carcinoma
    Park, Silvia
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Kang, Won Ki
    Park, Young Suk
    Cho, Jin Hyun
    Lim, Ho Yeong
    CHEMOTHERAPY, 2010, 56 (06) : 485 - 491
  • [38] RETROSPECTIVE US CLAIMS DATABASE ANALYSIS OF THE COST OF SEQUENCING OF SORAFENIB AND SUNITINIB IN THE TREATMENT OF PATIENTS WITH RENAL CELL CARCINOMA (RCC)
    Moyneur, E.
    Dorff, T.
    Barghout, V
    Meyers, S.
    Hu, J.
    Quinn, D.
    VALUE IN HEALTH, 2010, 13 (03) : A33 - A33
  • [39] Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma
    Aksu, G.
    Ensaroglu, F.
    Dolasik, I.
    Temiz, S.
    Halis, H.
    Sener, S. Y.
    Kaya, A.
    Uygun, K.
    JOURNAL OF BUON, 2010, 15 (04): : 798 - 799
  • [40] Long-term response to sunitinib treatment in metastatic renal cell carcinoma (mRCC).
    Tannir, Nizar M.
    Figlin, Robert A.
    Gore, Martin Eric
    Michaelson, Dror
    Motzer, Robert J.
    Porta, Camillo
    Rini, Brian I.
    Hoang, Caroline J.
    Lin, Xun
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345